$DFTX 8-K SEC Filings

Filed On	Filing
14 Sep 2026	8-K: Regulation FD Disclosure; Other Events This presentation (the “Presentation”) has been prepared by Definium Therapeutics, Inc. (“Definium”, the “Company”, “we”, “ou r” or “us") solely for informational purposes. This Presentation does not constitute an offering of, or a solic...
08 Sep 2026	8-K: Other Events Definium Therapeutics Receives Breakthrough Therapy Designation for DT120 (lysergide) Orally Disintegrating Tablet (ODT) in Major Depressive Disorder (MDD) Following Positive Phase 3 Results
12 Aug 2026	8-K: Regulation FD Disclosure; Other Events
06 Aug 2026	8-K: Results of Operations and Financial Condition
24 Jun 2026	8-K: Entry into a Material Definitive Agreement; Other Events
22 Jun 2026	8-K: Regulation FD Disclosure; Other Events
12 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
19 May 2026	8-K: Other Events
12 May 2026	8-K: Other Events
07 May 2026	8-K: Results of Operations and Financial Condition
22 Apr 2026	8-K: Other Events
26 Feb 2026	8-K: Results of Operations and Financial Condition
29 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation
12 Jan 2026	8-K: Results of Operations and Financial Condition; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
06 Nov 2025	8-K: Results of Operations and Financial Condition; Other Events
31 Oct 2025	8-K: Entry into a Material Definitive Agreement; Other Events
29 Oct 2025	8-K: Results of Operations and Financial Condition; Other Events
04 Sep 2025	8-K: Other Events
31 Jul 2025	8-K: Results of Operations and Financial Condition; Other Events
16 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

Comments